Evidence map›Paper›PMID 34775542›Full record

SynthesisBiological trace element research2022

Oral Magnesium Supplementation for the Prevention of Preeclampsia: a Meta-analysis or Randomized Controlled Trials.

Jing Yuan, Ying Yu, Tongyu Zhu, Xiaohan Lin, Xincheng Jing, Juan Zhang

Abstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Biological trace element research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Dietary supplements and prevention of preeclampsia.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Observational
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jing Yuan *Department of Medical Information, The 960th Hospital of the People's Liberation Army of China, Jinan, 250031, China.
Ying Yu *Department of Obstetrics, Zhangqiu District People's Hospital, Jinan, 250200, China.
Tongyu ZhuDepartment of Gynecology and Obstetrics, The 960th Hospital of the People's Liberation Army of China, No. 25 Shifan Road, Jinan, 250031, China. tongyuzhu_0293@21cn.com.ORCID http://orcid.org/0000-0002-9287-3698
Xiaohan LinDepartment of Gynecology and Obstetrics, The 960th Hospital of the People's Liberation Army of China, No. 25 Shifan Road, Jinan, 250031, China.
Xincheng JingDepartment of Gynecology and Obstetrics, The 960th Hospital of the People's Liberation Army of China, No. 25 Shifan Road, Jinan, 250031, China.
Juan ZhangDepartment of Gynecology and Obstetrics, The 960th Hospital of the People's Liberation Army of China, No. 25 Shifan Road, Jinan, 250031, China.
117th Hospital of People's Liberation Army · CNPeople's Liberation Army 401 Hospital · CNZhangqiu City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies evaluating the role of magnesium supplementation as a preventative strategy for preeclampsia showed inconsistent results. We performed a meta-analysis or randomized controlled trials (RCTs) to evaluate the influence of oral magnesium supplementation on the incidence of preeclampsia in pregnant women. Relevant studies were obtained by search of Medline, Embase, and Cochrane's Library databases. A random effects model was used to pool the results. Influences of study characteristics of the outcome were evaluated by predefined subgroup analyses. Seven RCTs with 2653 pregnant women were included. Pooled results showed that oral magnesium supplementation during pregnancy significantly reduced the risk of preeclampsia (risk ratio [RR]: 0.76, 95% confidence interval [CI]: 0.59 to 0.98, P = 0.04) with no significant heterogeneity (P for Cochrane's Q test = 0.42, I

Indexed as

Pre-EclampsiaDietary SupplementsFemaleHumansMagnesiumPregnancyRandomized Controlled Trials as TopicMagnesiumMagnesiumMeta-analysisPreeclampsiaPregnancySupplementation

Identifiers

PMID34775542
OpenAlexW3212844877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.